3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
14
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
4
Lymphoid
3
Thoracic
1
Sarcoma
1
Other hematologic neoplasm
1
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
168
Lung Neoplasms
148
Adenocarcinoma of Lung
37
Small Cell Lung Carcinoma
23
Adenocarcinoma, Bronchiolo-Alveolar
20
Breast Neoplasms
15
Mesothelioma, Malignant
13
Colorectal Neoplasms
11
Colonic Neoplasms
10
Prostatic Neoplasms
9
Rectal Neoplasms
7
Ovarian Neoplasms
7
Breast Neoplasms, Male
7
Neoplasm Metastasis
6
Melanoma
6
Carcinoma, Ovarian Epithelial
6
Thymoma
5
Pleural Effusion, Malignant
5
Stomach Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Pain
4
Neoplasms
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Salivary Gland Neoplasms
3
Lymphoma, Large B-Cell, Diffuse
3
Head and Neck Neoplasms
3
Fallopian Tube Neoplasms
3
Esthesioneuroblastoma, Olfactory
3
Esophageal Neoplasms
3
Interventions
Proton Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Cardiotoxicity
×
Thoracic
×
Clear all
NCT04822077
2021-03-30
PROTHYM
Swedish Lung Cancer Study Group
Phase NA
Recruiting
40 enrolled